The better way

Forging a brighter future for in vitro testing.

LifeTaq was founded to make drug testing more reliable, less costly, and faster.

We believe better drug development is fundamental to the health and happiness of the human race. 

We believe the biotech sector has the potential to cure the worst diseases. Arrest the effects of aging. Alleviate suffering on a global scale.  

To do this, we need better, more reproducible data. We shouldn’t have to throw away millions in investment, and years of research, because clinical testing fails to fulfil the promise of a candidate drug. 

So, we decided to find a better way. 

Through automated 3D cell cultivation. Through a full, reliable testing service, made available to all alongside high-quality cell products.

This way, we can all rise to the challenges that face pharma, life-science companies, academia. Creating better drugs quicker. Controlling costs. 

Changing lives. 

Who we are

CEO
Manfred Taschner, CEO
Having started the previous decade working in preclinical vaccine development, Manfred saw first-hand how initially promising drug trials can collapse at the human-testing stage. He co-founded LifeTaq with the goal of simulating the human body at a much earlier stage in drug development—using high-quality 3D cell cultures and an innovative automated process to increase the reliability of trial data. An expert in cell culture and preclinical development/analysis, Manfred studied in Austria, Australia, and the US. Manfred is most excited by stem-cell research—which he believes holds the key to regenerative medicine—and tissue engineering.
CTO
Volker Lorber, CTO
Volker’s journey began in the Regulatory Affairs department of the AGES Federal Office of Medicines and Medical Devices. He then worked in preclinical drug/vaccine development before co-founding LifeTaq with Manfred, as a place where their idea of a better kind of drug trial could become a reality. Volker’s expertise lies in both 2D and 3D cell culture: Volker has worked with fibroblasts, endothelial cells, MSCs, keratinocytes, and tumor cells. Volker is excited by CRISPR, stem-cell research, and neuroscience.

Show me the future of biotech

Lower your time to market with our cell-culture products and services. Whether it’s a full experimental design, standalone cell culturing, or high-quality auxiliary products—we’ll help you achieve reliable results, fast.

Drop us a line